Esmethadone

右美沙酮

Report date: 2024/01/26 17:43:02
NME

Base Information

Drug NameEsmethadone
Drug Alias NameDextromethadone(S)-Methadoned-MethadoneS-Methadone (Relmada Therapeutics)+-Methadone (Relmada Therapeutics) +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalySwitzerland
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRelmada Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRelmada Therapeutics Inc
Inactive CompaniesMGGM LLC
Active IndicationsDepressive Disorder, Major
Inactive IndicationsDepressive Disorder, Treatment-ResistantNeuralgia

Other Information

ATC CodeN/A
Related LinksWikipedia